Why the study?
Does oral nifedipine reduce rest angina in patients with obstructive coronary artery disease refractory to propranolol and nitrates?
Does oral nifedipine reduce rest angina in patients with obstructive coronary artery disease refractory to propranolol and nitrates?
Nifedipine is highly effective in abolishing or reducing rest angina in patients with obstructive coronary artery disease who are refractory to standard therapy with propranolol and nitrates.
Answers are grounded in this paper and cite their sources.
May support nifedipine in refractory rest angina; hypothesis-generating and requires randomized confirmation before practice change.
Nineteen patients with recurrent rest angina were given oral nifedipine. All patients had chest discomfort refractory to propranolol and oral or topical nitrates given to tolerance. The addition of nifedipine, 30 to 120 mg daily, abolished rest angina in 14 patients, decreased its frequency in two, and had no effect in three patients. Five of seven patients on long-term nifedipine (mean, 6.2 +/- 3.4 months) remained free of rest pain. Of seven patients who had their nifedipine dose decreased or discontinued, five had recurrent rest angina. Of the 19 patients, 16 had coronary angiography. Five had three- vessel obstructive disease (greater than 75% lesion), six had two-vessel obstructive disease, and five had one-vessel obstructive disease. The remaining three unstudied patients had pathologic Q waves in the ECG. Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Jeffrey W. Moses (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: